Professor, Surgery, UCLA School of Medicine
Neurosurgery
Dr. Linda M. Liau, MD
|
|
Give Review
Linda Liau practices Neurosurgery. He researched medicine at Stanford University School of Medicine. Stanford University School of Medicine is one of the top medical schools in the US. Stanford University School of Medicine has a rank of 2 in research and a 25 in primary care He received 5 awards: "America's Top Doctors", "Top Doctors:LA Area", "America's Top Doctors for Cancer", "Top Doctors:Southern California" and "Fellow (FAANS)". Linda Liau is a published doctor. He has 32 publications published. The most current publication "Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Efficacy of Systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma.
- pH-weighted molecular imaging of Gliomas using amine chemical exchange saturation transfer MRI.
- HLA Markers DQ8 and DR53 Are Associated With Lymphocytic Hypophysitis and May Aid in Differential Diagnosis.
- Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy.
- MRI perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent glioblastoma treated with bevacizumab.
- Relationship Between [(18)F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas.
- Tumor suppressive miR-148a is silenced by CpG island hypermethylation in IDH1 mutant Gliomas.
- Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy.
- C-terminally truncated form of αB-crystallin is associated with IDH1 R132H mutation in anaplastic Astrocytoma.
- Nonlinear distortion correction of diffusion MR images improves quantitative DTI measurements in glioblastoma.
- Altered functional connectivity of the default mode network in diffuse Gliomas measured with pseudo-resting state fMRI.
- Autologous Tumor Lysate-pulsed Dendritic Cell Immunotherapy for Pediatric Patients with Newly Diagnosed or Recurrent High-grade Gliomas.
- Lyophilized Brain tumor specimens can be used for histologic, nucleic acid, and protein analyses after 1 year of room temperature storage.
- Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome.
- Quantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiochemotherapy.
- Comparison of Glioma-associated Antigen Peptide-loaded Versus Autologous Tumor Lysate-loaded Dendritic Cell Vaccination in Malignant Glioma Patients.
- Imaging biomarkers for antiangiogenic therapy in malignant Gliomas.
- Recurrent somatic mutation of FAT1 in multiple human Cancers leads to aberrant Wnt activation.
- Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation.
- Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation.
- Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant Gliomas.
- Probabilistic radiographic atlas of glioblastoma phenotypes.
- Use of language mapping to aid in resection of gliomas in eloquent Brain regions.
- IDH Mutations in Human Glioma.
- Endogenous vaults and bioengineered vault nanoparticles for treatment of glioblastomas: implications for future targeted therapies.
- Differential Sensitivity of Glioma- versus Lung Cancer-Specific EGFR Mutations to EGFR Kinase Inhibitors.
- Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.
- Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.
- Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients.
- Protective properties of radio-chemoresistant glioblastoma stem cell clones are associated with metabolic adaptation to reduced glucose dependence.
- BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles.
Schools
Stanford University School Of Medicine
UCLA Med Center
Procedures Preformed
- Cerebrospinal Fluid (CSF) Shunt - Insertion, Repair or Removal
- Craniectomy, Craniotomy, Surgery of Skull Base, Neuroendoscopy
- Stereotaxis
Conditions Treated
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Aneurysm
- Brain Cancer
- Cerebral Artery Thrombosis
- View All
Doctors Specialties
- Neurosurgery
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Select Plus HMO
- Select PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Connecticare
- First Health (Coventry Health Care) PPO
- Blue & Gold HMO
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- Medical Mutual of Ohio
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Heritage Signature
- SelectHealth
- Tufts Health Plans
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- America's Top Doctors
- Top Doctors:LA Area
- America's Top Doctors for Cancer
- Top Doctors:Southern California
- Fellow (FAANS)
Education
-
UCLA Medical Center -
Stanford University School of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center -
Santa Monica-UCLA Medical Center and Orthopaedic Hospital
Drug Facts
| NPI NUMBER | 1861417834 | |
| NPPES Provider LastName | LIAU | |
| NPPES Provider FirstName | LINDA | |
| NPPES Provider ZIPCode | 900950001 | |
| NPPES Provider State | CA | |
| Specialty Description | Neurosurgery | |
| Total Claim Count | 29.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861417834 |
| Last Name Of The Provider | LIAU |
| First Name Of The Provider | LINDA |
| View All |
Similar Doctors
|
|
Jacqueline S. King, NP |
|
|
Dr. John P. Johnson, MD |
|
|
Dr. Richard B. Williams, MD |
|
|
Dr. Eli M. Baron, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald Becker, MD |
|
|
Dr. Mark D. Krieger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ausaf A. Bari, MD |
|
|
Dr. Maria P. Eboli, MD |
|
|
Dr. Vivek A. Mehta, MD |
|
|
Dr. Tianyi Niu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yinn C. Ooi, MD |
|
|
Dr. Taghi Tirgari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Judith M. Wong, MD |
|
|
Dr. Yohsuke Fukami, MD
This Doctor is OpenDoctor Recommended.
|